Papers

3

Total Citations

37

H-Index

3

About

Dr. D. Brock Hewitt is a surgical oncologist whose research focuses on the frontiers of hepatopancreatobiliary (HPB) surgery and the safe implementation of innovative techniques. His most cited work provides a comprehensive overview of the surgical management of perihilar cholangiocarcinoma (pCCA), a rare and aggressive bile duct cancer, detailing current perspectives on this challenging disease. Dr. Hewitt is also a leading voice in the safe adoption of novel procedures, as demonstrated by his work on robotic-assisted nipple-sparing mastectomy and robotic pancreaticoduodenectomy. His 2022 paper on "Safe Technical Innovation" has become a foundational reference for surgeons integrating new technologies into practice. With over 30 citations for his pCCA review alone, Dr. Hewitt’s contributions are shaping the standard of care for complex oncologic resections. His recent advances in robotic pancreas surgery highlight his commitment to improving patient outcomes through minimally invasive approaches, solidifying his reputation as a surgeon-scientist dedicated to both technical excellence and patient safety.

Research Focus

Key Achievements

3
H-Index
3
Papers
37
Total Citations
12
Avg Citations/Paper
🏆 Most Cited Paper
Current Perspectives on the Surgical Management of Perihilar Cholangiocarcinoma
30 citations · 2022
📈 Most Prolific Year: 2022 (2 Papers)
🤝 Key Collaborators: 4
🏛 Institutions: The Ohio State University Wexner Medical Center, Creative Commons, New York University

Top Papers

  1. 1
  2. 2
    Safe Technical Innovation
    4 citations · 2022
  3. 3

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 15 days ago